calcium dialysate concentration of 1.75 mmol/L, intravenous vitamin D supplements, and oral calcium tablets as required, to keep adjCa levels within the desired range of 2.2 to 2.6 mmol/L.In the following six months, each participant was administered a maintenance dose of 10 mL of 10% intravenous calcium gluconate after every dialysis session, three times weekly.Adjusted calcium levels were assessed in the middle of each month.Results: A total of nine patients satisfied the inclusion criteria.All participants receiving intravenous calcium-gluconate supplementation three times a week successfully maintained their pre-dialysis adjCalcium levels above 2.2 mmol/L throughout the 6-month follow-up period, with no incidence of hypercalcemia.None of the patients needed hospital admissions due to hypocalcemia.The graph below depicts the median adjusted calcium levels prior to and following the intervention. Conclusion:The short term outcome of our intervention demonstrated effectiveness and were reassuringly safe.This suggests that alternative approaches, like intradialytic IV calcium gluconate, are suitable for outpatient settings and merit further exploration within the hemodialysis population that struggles with compliance to oral therapies.This technique may also help prevent hospitalizations for intravenous calcium treatment.However, we recommend additional validation before drawing more conclusive insights about this approach.It is important to recognize that the study has specific limitations, being a retrospective analysis with a relatively small sample size.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
Buhary et al. (Wed,) studied this question.